Sputnik V will be “two or more times cheaper than foreign vaccines based on mRNA technology with similar efficacy rates,” Russia’s sovereign wealth fund said.

Financial terms of the EU contract were not disclosed, but Moderna CEO Stephane Bancel said the company planned to charge governments between $25 and $37 per dose.